Project Number 5U01NS111671-03 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Therapeutic APOE2 overexpression for early Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator DAVIDSON, BEVERLY L. Principal Investigator First Name BEVERLY L. Principal Investigator Last Name DAVIDSON Awardee Organization CHILDREN'S HOSP OF PHILADELPHIA Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-542: CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U01 Clinical Trial Optional) FY Overall Cost $1,802,422 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official BOSHOFF, CHRIS
